Fingerprint
Dive into the research topics of 'Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
Fabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, Marcello Ceppi, Luca Boni, Filippo Montemurro, Stefania Russo, Claudia Bighin, Michelino De Laurentiis, Mario Giuliano, Giancarlo Bisagni, Antonio Durando, Anna Turletti, Ornella Garrone, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Adriano Gravina, Sabino De Placido, Francesco Cognetti
Research output: Contribution to journal › Article › peer-review